A sweeping decision threatens to unravel one of the most important pathways to care post-Dobbs.
Nina Martin, Mother Jones
May 1, 2026
A federal appeals court packed with conservatives has handed abortion opponents a major victory against the US Food and Drug Administration, reinstating an in-person dispensing requirement for the abortion medication mifepristone and shutting down telemedicine providers—at least temporarily—from prescribing the abortion pill across the US.
In a 3-0 order issued Friday afternoon, the Fifth US Circuit Court of Appeals granted Louisiana’s request for an injunction against FDA rule changes from 2023 that have allowed blue-state telehealth providers to send mifepristone to thousands of patients every month in states where abortion is banned. Abortion pills now account for almost two-thirds of abortions nationwide.